$0.3971
-0.0057-1.42%
At close: Aug 7, 5:00 PM EST
$0.3944
-0.0027-0.68%
After Hours: 4:22 PM EST
Werewolf Therapeutics (HOWL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.31 | $-0.30 | $-0.34 | $-0.39 |
| Actual | $0.08 | $-0.28 | $-0.20 | $-0.36 |
| Surprise | +125.8% | +6.67% | +41.2% | +7.69% |
| Revenue | ||||
| Estimate | — | — | $600000 | $600000 |
| Actual | $21.0M | $0 | $0 | $0 |
| Surprise | — | — | -100.0% | -100.0% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.30 | $-0.23 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 31, 2026 | $0.08 | $-0.31 | 125.8 % |
| Q1 | May 7, 2026 | $-0.28 | $-0.30 | 6.67 % |
| Q4 | Mar 27, 2026 | $-0.20 | $-0.34 | 41.2 % |
| Q3 | Nov 4, 2025 | $-0.36 | $-0.39 | 7.69 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 27, 2026 | $0 | $600.00K | -100.0 % |
| Q3 | Nov 4, 2025 | $0 | $600.00K | -100.0 % |
| Q2 | Aug 14, 2025 | $0 | $600.00K | -100.0 % |
| Q1 | May 8, 2025 | $0 | $300.00K | -100.0 % |